TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹461 Cr | ₹-253 Cr | ₹319 Cr | ₹30 Cr | ₹-175 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹461 Cr |
| Mar2025 | ₹-253 Cr |
| Mar2024 | ₹319 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹-175 Cr |
How is Net Cash Inflow / Outflow of TORRENT PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹461 Cr | Positive | |
| Mar2025 | ₹-253 Cr | Negative | |
| Mar2024 | ₹319 Cr | 955.47 | |
| Mar2023 | ₹30 Cr | Positive | |
| Mar2022 | ₹-175 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹178,742.4 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
| MANKIND PHARMA | ₹109,880.0 Cr | 1.3% | 16.8% | 17.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.2% |
1.9% |
20.9% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses